돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 472779생성일: 2026년 10월 23일

3-(1-Methylpyrrolidin-2-yl)pyridine → Dopamine

https://huagongshe.com/ko/reaction/472779

반응식

참여 물질

역할이름HCID투입량
반응물3-(1-Methylpyrrolidin-2-yl)pyridineHCID 942—
반응물3H-dopamineHCID 57350278—
생성물DopamineHCID 681—

반응 단계

The synaptosomal suspension was incubated for 10 minutes at 37° C. to restore metabolic activity. [3H]Dopamine ([3H]DA, specific activity=28.0 Ci/mmol, NEN Research Products) was added at a final concentration of 0.1 μM and the suspension was incubated at 37° C. for another 10 minutes. 50 μL aliquots of tissue+100 μL perfusion buffer were loaded into the suprafusion chambers of a Brandel Suprafusion System (series 2500, Gaithersburg, Md.). Perfusion buffer (room temperature) was pumped into the chambers at a rate of 3 ml/min for a wash period of 8 minutes. Test compound (10 μM) or nicotine (10 μM) was then applied in the perfusion stream for 40 seconds. Fractions (12 seconds each) were continuously collected from each chamber throughout the experiment to capture basal release, agonist-induced peak release and to re-establish the baseline after the agonist application. The perfusate was collected directly into scintillation vials, to which scintillation fluid was added. [3H]DA released was quantified by scintillation counting. For each chamber, the integrated area of the peak was normalized to its baseline.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08633222B2
출처 데이터셋uspto-grants-2014_01
ORD IDord-d6aedc95c4304d92b52613f5587880c4
출처 메모uspto-grants-2014_01